1. Home
  2. RFL vs WYY Comparison

RFL vs WYY Comparison

Compare RFL & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • WYY
  • Stock Information
  • Founded
  • RFL 2017
  • WYY 1991
  • Country
  • RFL United States
  • WYY United States
  • Employees
  • RFL N/A
  • WYY N/A
  • Industry
  • RFL Real Estate
  • WYY EDP Services
  • Sector
  • RFL Finance
  • WYY Technology
  • Exchange
  • RFL Nasdaq
  • WYY Nasdaq
  • Market Cap
  • RFL 54.4M
  • WYY 48.9M
  • IPO Year
  • RFL N/A
  • WYY 1998
  • Fundamental
  • Price
  • RFL N/A
  • WYY $5.62
  • Analyst Decision
  • RFL
  • WYY Strong Buy
  • Analyst Count
  • RFL 0
  • WYY 3
  • Target Price
  • RFL N/A
  • WYY $8.00
  • AVG Volume (30 Days)
  • RFL 175.2K
  • WYY 55.0K
  • Earning Date
  • RFL 11-05-2025
  • WYY 11-12-2025
  • Dividend Yield
  • RFL N/A
  • WYY N/A
  • EPS Growth
  • RFL N/A
  • WYY N/A
  • EPS
  • RFL N/A
  • WYY N/A
  • Revenue
  • RFL $732,000.00
  • WYY $144,421,640.00
  • Revenue This Year
  • RFL N/A
  • WYY $9.19
  • Revenue Next Year
  • RFL N/A
  • WYY $13.16
  • P/E Ratio
  • RFL N/A
  • WYY N/A
  • Revenue Growth
  • RFL 35.56
  • WYY 16.25
  • 52 Week Low
  • RFL $1.28
  • WYY $2.19
  • 52 Week High
  • RFL $3.19
  • WYY $6.25
  • Technical
  • Relative Strength Index (RSI)
  • RFL 40.95
  • WYY 62.78
  • Support Level
  • RFL $1.35
  • WYY $5.00
  • Resistance Level
  • RFL $1.38
  • WYY $5.39
  • Average True Range (ATR)
  • RFL 0.09
  • WYY 0.30
  • MACD
  • RFL 0.00
  • WYY -0.03
  • Stochastic Oscillator
  • RFL 10.00
  • WYY 92.11

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

Share on Social Networks: